SCHEMBL6442647

SCHEMBL6442647

ClCCCCN1CCCC1

nearest known ligand 0.65

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 8/20 0.65
MAPT P10636 1/20 0.50
CYP1A2 P05177 2/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
SIGMAR1 Q99720 1/20 0.42
CXCR4 P61073 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6443177 0.97 HRH3 (0.70) HRH3MAPTCYP1A2CYP2D6CYP2C19
SCHEMBL6444083 0.97 HRH3 (0.70) HRH3MAPTCYP1A2L3MBTL1MAPK1
Hydrochloric Acid SCHEMBL8490153 0.97 HRH3 (0.62) HRH3MAPTCYP1A2CYP2D6CYP2C19
SCHEMBL2747040 0.97 HRH3 (0.70) HRH3MAPTCYP1A2L3MBTL1MAPK1
SCHEMBL6442159 0.97 HRH3 (0.70) HRH3MAPTCYP1A2CYP2D6CYP2C19
SCHEMBL6444053 0.95 HRH3 (0.75) HRH3MAPTCYP1A2MAPK1SMN1; SMN2
SCHEMBL6443349 0.95 HRH3 (0.75) HRH3MAPTCYP1A2MAPK1SMN1; SMN2
SCHEMBL6447947 0.95 HRH3 (0.75) HRH3MAPTCYP1A2MAPK1SMN1; SMN2
Hydrochloric Acid SCHEMBL7101066 0.95 HRH3 (0.67) HRH3MAPTCYP1A2L3MBTL1MAPK1
SCHEMBL6442289 0.95 HRH3 (0.75) HRH3MAPTCYP1A2MAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107698539-A The preparation method of Buflomedil Hydrochloride 陕西启源科技发展有限责任公司 2018-02-16 CN claimed
CN-107698539-A The preparation method of Buflomedil Hydrochloride 陕西启源科技发展有限责任公司 2018-02-16 CN disclosed
CN-101486701-B Chromanone compound and analogue and medical application thereof UNIV SHENYANG PHARMACEUTICAL 2013-06-19 CN disclosed
US-6858679-B2 Compositions providing improved functionalization of terminal anions and processes for improved functionalization of terminal anions FMC CORPORATION (US) 2005-02-22 US disclosed
US-20030153693-A1 Compositions providing improved functionalization of terminal anions and processes for improved functionalization of terminal anions QUIRK RODERIC PAUL (US) 2003-08-14 US disclosed
US-6605564-B1 Anionic polymerization initiators and salt additives selected from sodium chloride, sodium iodide, potassium chloride, potassium t-butoxide, for increasing the efficiency of reactions between living polymer anions and electrophiles FMC CORPORATION 2003-08-12 US disclosed
US-6545103-B2 Living polymers FMC CORPORATION 2003-04-08 US disclosed
US-20020010082-A1 Compositions providing improved functionalization of terminal anions and processes for improved functionalization of terminal anions FMC CORPORATION 2002-01-24 US disclosed
EP-0128502-B1 SUBSTITUTED 6-(THIEN-2-YL)-3(2H)-PYRIDAZINONES AND PROCESSES FOR THEIR PREPARATION A. Nattermann & Cie. GmbH (DE) 1988-08-31 EP disclosed
EP-0040793-B1 NOVEL QUINAZOLINE-DIONE COMPOUNDS, PROCESS FOR PRODUCTION THEREOF AND PHARMACEUTICAL USE THEREOF Ishikawa, Masayuki (JP) 1985-08-28 EP disclosed
EP-0128502-A1 Substituted 6-(thien-2-yl)-3(2H)-pyridazinones and processes for their preparation A. Nattermann & Cie. GmbH (DE) 1984-12-19 EP disclosed
US-4405623-A HYPOTENSIVE AGENTS, VASODILATORS MASAYUKI ISHIKAWA (JP) 1983-09-20 US disclosed
US-4357280-A Use of tertiary phosphines in photographic silver dye bleach materials CIBA-GEIGY AG (CH) 1982-11-02 US disclosed
EP-0040793-A1 Novel quinazoline-dione compounds, process for production thereof and pharmaceutical use thereof Ishikawa, Masayuki (JP) 1981-12-02 EP disclosed
US-4138256-A Method of processing photographic silver dye bleach materials CIBA-GEIGY AG (CH) 1979-02-06 US disclosed
US-3953425-A Azepine indanyl and tetralin butyrophenones THE UPJOHN COMPANY (US) 1976-04-27 US disclosed